Avid Bio field­ing client in­quiries due to Chi­na bill; Ox­ford Bio wants to dou­ble its rev­enues

Wel­come to End­points News’ man­u­fac­tur­ing briefs, where we bring you es­sen­tial news on new builds, col­lab­o­ra­tions, re­calls and more.

Avid Bioser­vices has de­tect­ed an uptick …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.